Sign in
VRAX Stock Price, Chart, Stats & News
Virax Biolabs Group Limited
Save
Virax Biolabs Group Limited (VRAX) does not currently pay a dividend.
699,097
Market cap
–
Current P/E
–
Forward P/E
VRAX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -8774.51% |
Operating margin | -196566.68% |
Pretax margin | -198510.88% |
Net margin | -189001.71% |
Effective tax rate | 4.62% |
ROA | -98.75% |
ROE | -102.54% |
D/E | 0.10x |
Interest coverage ratio | -92.32x |
VRAX valuation
P/E | – |
P/S | 231.64x |
P/B | 0.14x |
P/CF | -0.14x |
P/FCF | -0.11x |
P/OCF | -0.14x |
PEG | -0.01x |
EV multiple | -0.64x |
About
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.
Similar securities
Based on sector and market capitalization
Report issue